SCNX ▲ +16.7% - Scienture Holdings, Inc. $SCNX - SCIENTURE Expands Commercial Reach of REZENOPY™ to Addiction Treatment Centers through an Agreement with a Distribution Partner Scienture Holdings shares surged 16.7% following the company's announcement of a distribution partnership to expand commercial availability of its REZENOPY™ product to addiction treatment centers. The deal marks a significant step in broadening the drug's market reach beyond its current channels, signaling progress in the company's commercialization strategy for the addiction treatment space. 22-SEP-2026 08:15 AM ET